Stearidonic acid raises red blood cell membrane eicosapentaenoic acid.

  title={Stearidonic acid raises red blood cell membrane eicosapentaenoic acid.},
  author={K. Maki and T. M. Rains},
  journal={The Journal of nutrition},
  volume={142 3},
The consumption of EPA and DHA has been associated with reduced risk for cardiovascular disease morbidity and mortality. Mean intakes of EPA and DHA in the United States and elsewhere are below levels recommended by health authorities. The main non-marine source of dietary (n-3) fatty acids (α-linolenic acid) is poorly converted to EPA in humans. Stearidonic acid (SDA) is a non-marine fatty acid that appears to be more readily converted to EPA in humans. Results from previous studies suggested… Expand
Plant-based stearidonic acid as sustainable source of omega-3 fatty acid with functional outcomes on human health
Botanical stearidonic acid (SDA, 18:4n-3) rich oils are emerging as a sustainable omega-3 source with efficient conversion rate to n-3 LC-PUFA especially to EPA, as it bypasses the Δ6-desaturase rate limiting step. Expand
Dietary echium oil increases long-chain n-3 PUFAs, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome.
Overall, daily intake of 15-20 g EO increased EPA and DPA in blood but had no influence on DHA, which suggests natural EO could be a noteworthy source of n-3 PUFA in human nutrition. Expand
Omega-3 fatty acid supplementation and cardiovascular disease
The outcome of the analysis reveals that nonfish sources of ω 3 PUFA vary in their capacity to regulate blood levels of C20–22 ω3 PUFA and CVD risk factors. Expand
Wax Ester Rich Oil From The Marine Crustacean, Calanus finmarchicus, is a Bioavailable Source of EPA and DHA for Human Consumption
A novel wax ester rich marine oil is a suitable alternative source of EPA and DHA for human consumption in a randomized, two-period crossover study. Expand
Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases Omega-3 fatty acid supplementation and cardiovascular disease
An analysis of omega-3 fatty acid metabolism and the capacity of 3 PUFA supplements to regulate key cellu- lar events linked to CVD reveals that nonfi sh sources of 3PUFA vary in their ability to regulate blood levels of C 20-22 3 PU FA and CVD risk factors. Expand
Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?
Although RCT data accumulated to date have failed to provide unequivocal evidence of CVD risk reduction with n-3 PUFA supplementation, many studies were limited by design issues, including low dosage, no assessment of n- 3 status, and absence of a clear biological target or pathophysiologic hypothesis for the intervention. Expand
Conclusions and recommendations from the symposium, Heart Healthy Omega-3s for Food: Stearidonic Acid (SDA) as a Sustainable Choice.
Faculty who had presented at the symposium "Heart Healthy Omega-3s (n-3 fatty acids) for Food: Stearidonic Acid (SDA) as a Sustainable Choice" met and agreed upon conclusions and recommendations thatExpand
The Role of Essential Fatty Acids in Human Health
Current understanding of the pervasive roles of essential fatty acids and their metabolites in human health, including cardiovascular disease and mental health, are summarized. Expand
Emerging Industrial Oil Crops
Abstract It is now the age of the biobased economy, with great efforts expended in both basic and applied research to develop useful products from agriculture that replace those derived fromExpand


Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids.
BACKGROUND For many persons who wish to obtain the health benefits provided by dietary n-3 fatty acids, daily ingestion of fish or fish oil is not a sustainable long-term approach. To increase theExpand
Stearidonic Acid-Enriched Soybean Oil Increased the Omega-3 Index, an Emerging Cardiovascular Risk Marker
Since EPA supplementation has been shown to raise the Omega-3 index and to lower risk for cardiac events, SDA-SBO may be a viable plant-based alternative for providing meaningful intakes of cardioprotective omega-3 FAs. Expand
Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content.
  • E. Krul, S. Lemke, +7 authors K. Maki
  • Biology, Medicine
  • Prostaglandins, leukotrienes, and essential fatty acids
  • 2012
SDA increased RBC %EPA in a dosage and time-dependent manner at intakes as low as 1.3 g/d, significantly increasing the likelihood of incorporation into red blood cell (RBC) membranes over time. Expand
Omega-3 Fatty Acids in Cardiac Biopsies From Heart Transplantation Patients: Correlation With Erythrocytes and Response to Supplementation
RBC EPA-DHA was highly correlated with cardiac EPA+DHA; the RBC omega-3 response to supplementation was similar to that of the heart; RBCs are easily collected and analyzed and they have a less variable FA composition than plasma. Expand
alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans.
The DHA status of infants and adults consuming preformed DHA in their diets is, on average, greater than that of people who do not consume DHA, but not with supplementation of ALA, EPA, or other precursors. Expand
Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults.
Stable isotope tracer studies indicate that conversion of alphaLNA to EPA occurs but is limited in men and that further transformation to DHA is very low, and capacity to up-regulatealphaLNA conversion in women may be important for meeting the demands of the fetus and neonate for DHA. Expand
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.
Evidence from epidemiological studies and RCTs will be reviewed, and recommendations reflecting the current state of knowledge will be made with regard to both fish consumption and omega-3 fatty acid (plant- and marine-derived) supplementation. Expand
The Omega-3 Index: a new risk factor for death from coronary heart disease?
The Omega-3 Index may represent a novel, physiologically relevant, easily modified, independent, and graded risk factor for death from CHD that could have significant clinical utility. Expand
Effects of dietary alpha-linolenic acid on the conversion and oxidation of 13C-alpha-linolenic acid.
Conversion of 13C-ALA into its LCP may be decreased on diets rich in ALA, while oxidation of 12C- ALA is negatively correlated with its conversion into longer-chain polyunsaturates (LCP). Expand
Effects of dietary α-linolenic acid on the conversion and oxidation of13C-α-linolenic acid
Conversion of13C-ALA into its LCP may be decreased on diets rich in ALA, while oxidation of 13C- ALA is negatively correlated with its conversion into longer-chain polyunsaturates (LCP). Expand